Gaussian-based 3D-QSAR and Pharmacophore Mapping Studies of Indole Derivatives as Aromatase Inhibitors
The designed compound S1 demonstrated a predicted IC50 value of 9.332 nM, comparable to the most active compound 15 and the standard reference Letrozole. The developed models may be utilized by medicinal chemists for the optimization of new indole-based aromatase inhibitors for the effective treatment of ER+ breast cancer.
Authors
- Neha Bhatia (ORCID: https://orcid.org/0000-0002-0416-8543)
- Suresh Thareja (ORCID: https://orcid.org/0000-0001-7668-462X)
Institutions
- Central University of Punjab (IN)
Publication Details
- Journal
- Anti-Cancer Agents in Medicinal Chemistry
- Published
- 2025-08-12
- DOI
- https://doi.org/10.2174/0118715206390949250805064957
- Primary Topic
- Estrogen and related hormone effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00